We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...
Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société de biotechnologie de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes...
Consolidated revenue of €3.4m at the end of September 2024 Cash position of €4.1m before receipt of IRIS Pharma’s CIR (€610k) as of September 30, 2024 Live broadcast of the General Meeting on...
Proposed appointment of Jean-Gérard Galvez, Luc Demarre and Caroline DeSurmont as directors Proposed financial delegations necessary for the Company's development Proposed amendments to the...
Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.046 | -3.59937402191 | 1.278 | 1.326 | 1.212 | 42421 | 1.26019356 | DE |
4 | -0.07 | -5.37634408602 | 1.302 | 1.35 | 1.2 | 42558 | 1.28576401 | DE |
12 | -0.078 | -5.95419847328 | 1.31 | 1.5 | 1.128 | 49687 | 1.29295334 | DE |
26 | -0.068 | -5.23076923077 | 1.3 | 1.5 | 1.11 | 42359 | 1.28660499 | DE |
52 | -0.076 | -5.81039755352 | 1.308 | 1.5 | 0.91 | 50212 | 1.22475259 | DE |
156 | -1.148 | -48.2352941176 | 2.38 | 3.57 | 0.91 | 102293 | 1.83075104 | DE |
260 | 0.882 | 252 | 0.35 | 3.57 | 0.32 | 245635 | 1.41206377 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions